Exact Mass: 429.1987642
Exact Mass Matches: 429.1987642
Found 96 metabolites which its exact mass value is equals to given mass value 429.1987642
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
7-Benzylidenenaltrexone
C27H27NO4 (429.19399820000007)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists
Abiraterone sulfate
C24H31NO4S (429.19736860000006)
Abiraterone sulfate is a metabolite of abiraterone. Abiraterone is a drug used in castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) (prostate cancer not responding to androgen deprivation or treatment with antiandrogens). It is formulated as the prodrug abiraterone acetate and marketed under the trade name Zytiga. After an expedited six-month review, abiraterone was approved by the U.S. Food and Drug Administration (FDA) in April 2011. (Wikipedia)
7-Benzylidenenaltrexone
C27H27NO4 (429.19399820000007)
Hippuryl-histidyl-leucine
C21H27N5O5 (429.20120920000005)
2-(2-(4-Phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid
C27H27NO4 (429.19399820000007)
8-Benzylcanadine
C27H27NO4 (429.19399820000007)
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.163 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.170
Ala Gly Pro Trp
C21H27N5O5 (429.20120920000005)
Ala Gly Trp Pro
C21H27N5O5 (429.20120920000005)
Ala Pro Gly Trp
C21H27N5O5 (429.20120920000005)
Ala Pro Trp Gly
C21H27N5O5 (429.20120920000005)
Ala Trp Gly Pro
C21H27N5O5 (429.20120920000005)
Ala Trp Pro Gly
C21H27N5O5 (429.20120920000005)
Gly Ala Pro Trp
C21H27N5O5 (429.20120920000005)
Gly Ala Trp Pro
C21H27N5O5 (429.20120920000005)
Gly Pro Ala Trp
C21H27N5O5 (429.20120920000005)
Gly Pro Trp Ala
C21H27N5O5 (429.20120920000005)
Gly Trp Ala Pro
C21H27N5O5 (429.20120920000005)
Gly Trp Pro Ala
C21H27N5O5 (429.20120920000005)
Pro Ala Gly Trp
C21H27N5O5 (429.20120920000005)
Pro Ala Trp Gly
C21H27N5O5 (429.20120920000005)
Pro Gly Ala Trp
C21H27N5O5 (429.20120920000005)
Pro Gly Trp Ala
C21H27N5O5 (429.20120920000005)
Pro Trp Ala Gly
C21H27N5O5 (429.20120920000005)
Pro Trp Gly Ala
C21H27N5O5 (429.20120920000005)
Trp Ala Gly Pro
C21H27N5O5 (429.20120920000005)
Trp Ala Pro Gly
C21H27N5O5 (429.20120920000005)
Trp Gly Ala Pro
C21H27N5O5 (429.20120920000005)
Trp Gly Pro Ala
C21H27N5O5 (429.20120920000005)
Trp Pro Ala Gly
C21H27N5O5 (429.20120920000005)
Trp Pro Gly Ala
C21H27N5O5 (429.20120920000005)
(S)-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-(4-ISOPROPYL-PHENYL)-PROPIONIC ACID
C27H27NO4 (429.19399820000007)
4-[BUTYL([2-(1H-TETRAZOL-5-YL)[1,1-BIPHENYL]-4-YL]METHYL)AMINO]-5-PYRIMIDINECARBOXYLIC ACID
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(3-methylphenyl)-N-(3-pyridinylmethyl)- (9CI)
C25H27N5S (429.19870620000006)
3-{2-[4-(4-fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
C23H28FN3O4 (429.20637400000004)
17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol hydrochlori de dihydrate
C21H32ClNO6 (429.19180420000004)
6-[2-Oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-(phenylmethyl)-7-triazolo[4,5-d]pyrimidinone
(6E)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
C27H27NO4 (429.19399820000007)
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-7-(phenylmethylene)-, (5alpha)-
C27H27NO4 (429.19399820000007)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists
2-Amino-6-ethyl-4-(4-methoxyphenyl)-8-[(4-methoxyphenyl)methyl]-4,5-dihydropyrano[3,2-c]pyridine-3-carbonitrile
C26H27N3O3 (429.20523120000007)
4-[[[2-(1-Azepanyl)ethyl-(2-furanylmethyl)amino]-sulfanylidenemethyl]amino]benzoic acid ethyl ester
C23H31N3O3S (429.20860160000007)
2-[cyclohexyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)acetamide
C23H31N3O3S (429.20860160000007)
1-methyl-4-[2-oxo-2-(N-(phenylmethyl)anilino)ethyl]-5-pyrrolo[3,2-b]pyrrolecarboxylic acid propan-2-yl ester
C26H27N3O3 (429.20523120000007)
(4As,6Z,7aR,12bS)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
C27H27NO4 (429.19399820000007)
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
(3S,12Z)-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.018,23]hexacosa-1(15),8,12,17(26),18(23),19,24-heptaene-4,10-dione
C26H27N3O3 (429.20523120000007)
(3S,12Z)-14,14,21,21-tetramethyl-20-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.019,24]hexacosa-1(15),8,12,17(26),18,22,24-heptaene-4,10-dione
C26H27N3O3 (429.20523120000007)
[(8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulate
C24H31NO4S (429.19736860000006)
4F 4PP (oxalate)
C24H28FNO5 (429.19514100000004)
4F 4PP (oxalate) is a selective 5-HT2A antagonist with almost as high affinity (Ki= 5.3 nM) as ketanserin but with a much lower affinity for 5-HT2C sites (Ki= 620 nM)[1][2][3][4].
(3s)-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.0³,¹¹.0⁵,⁹.0¹⁷,²⁶.0¹⁸,²³]hexacosa-1(15),8,12,17,19,23,25-heptaene-4,10-dione
C26H27N3O3 (429.20523120000007)
1,2-dihydroxy-12-(2-hydroxy-2-methylpropyl)-7-methoxy-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione
C22H27N3O6 (429.18997620000005)
(1r,3r,5s,6r,7s)-7-(acetyloxy)-8-methyl-3-(1-methylpyrrole-2-carbonyloxy)-8-azabicyclo[3.2.1]octan-6-yl 1-methylpyrrole-2-carboxylate
C22H27N3O6 (429.18997620000005)
(1r,2s,12s,15s)-1,2-dihydroxy-12-(2-hydroxy-2-methylpropyl)-7-methoxy-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione
C22H27N3O6 (429.18997620000005)
(1s,2s,12s,15s)-1,2-dihydroxy-12-(2-hydroxy-2-methylpropyl)-7-methoxy-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione
C22H27N3O6 (429.18997620000005)
14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.0³,¹¹.0⁵,⁹.0¹⁷,²⁶.0¹⁸,²³]hexacosa-1(15),8,12,17,19,23,25-heptaene-4,10-dione
C26H27N3O3 (429.20523120000007)